JP2010533178A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533178A5
JP2010533178A5 JP2010516041A JP2010516041A JP2010533178A5 JP 2010533178 A5 JP2010533178 A5 JP 2010533178A5 JP 2010516041 A JP2010516041 A JP 2010516041A JP 2010516041 A JP2010516041 A JP 2010516041A JP 2010533178 A5 JP2010533178 A5 JP 2010533178A5
Authority
JP
Japan
Prior art keywords
nucleic acid
ligand
acid molecules
molecules encoding
cationic liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010516041A
Other languages
English (en)
Japanese (ja)
Other versions
JP5890095B2 (ja
JP2010533178A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/008394 external-priority patent/WO2009009054A1/en
Publication of JP2010533178A publication Critical patent/JP2010533178A/ja
Publication of JP2010533178A5 publication Critical patent/JP2010533178A5/ja
Application granted granted Critical
Publication of JP5890095B2 publication Critical patent/JP5890095B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010516041A 2007-07-09 2008-07-09 カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法 Expired - Fee Related JP5890095B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92968507P 2007-07-09 2007-07-09
US60/929,685 2007-07-09
PCT/US2008/008394 WO2009009054A1 (en) 2007-07-09 2008-07-09 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014089131A Division JP2014148533A (ja) 2007-07-09 2014-04-23 カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法

Publications (3)

Publication Number Publication Date
JP2010533178A JP2010533178A (ja) 2010-10-21
JP2010533178A5 true JP2010533178A5 (https=) 2011-04-14
JP5890095B2 JP5890095B2 (ja) 2016-03-22

Family

ID=40228915

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010516041A Expired - Fee Related JP5890095B2 (ja) 2007-07-09 2008-07-09 カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法
JP2014089131A Pending JP2014148533A (ja) 2007-07-09 2014-04-23 カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014089131A Pending JP2014148533A (ja) 2007-07-09 2014-04-23 カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法

Country Status (15)

Country Link
US (1) US20090053299A1 (https=)
EP (1) EP2175835B1 (https=)
JP (2) JP5890095B2 (https=)
KR (2) KR101570886B1 (https=)
CN (2) CN101801344A (https=)
AU (1) AU2008275713B2 (https=)
BR (1) BRPI0814558A2 (https=)
CA (1) CA2692546C (https=)
EA (1) EA201070050A1 (https=)
IL (1) IL203204B (https=)
MX (1) MX2010000166A (https=)
NZ (1) NZ582414A (https=)
SG (1) SG182994A1 (https=)
WO (1) WO2009009054A1 (https=)
ZA (1) ZA201000038B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5573111B2 (ja) * 2009-11-06 2014-08-20 ライオン株式会社 イソプロピルメチルフェノール含有液体口腔用組成物
US20110182976A1 (en) * 2010-01-28 2011-07-28 National Taiwan Ocean University Lipoplex-patch based dna vaccine
CN102858367B (zh) * 2010-02-26 2014-12-17 国立大学法人长崎大学 抗原或药物递送复合物
RS63890B1 (sr) * 2010-08-31 2023-02-28 Glaxosmithkline Biologicals Sa Mali lipozomi za isporuku rnk koja kodira imunogen
US8932575B2 (en) 2010-09-21 2015-01-13 University Of Miami Compositions and methods for inducing migration by dendritic cells and an immune response
WO2012040266A2 (en) * 2010-09-24 2012-03-29 University Of Miami Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
SG2013014170A (en) * 2012-09-19 2014-04-28 Univ Georgetown Targeted liposomes
CN103405386B (zh) * 2012-09-21 2016-05-18 上海泽润生物科技有限公司 一种脂质体的制备方法及制作脂质体佐剂的方法
WO2014159917A2 (en) 2013-03-14 2014-10-02 Georgetown University Treatment for exposure to nerve agent
CN105726485B (zh) * 2016-03-24 2019-08-06 东华大学 一种半乳糖化壳聚糖修饰的免疫醇质体的制备方法
WO2020117715A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment
CN111840538A (zh) * 2020-05-29 2020-10-30 中山大学 一种水痘-带状疱疹病毒亚单位纳米疫苗的制备方法和应用
CN117883382B (zh) * 2023-11-27 2025-02-14 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 高效递送疫苗的脂质体载体及脂质体疫苗的制备与用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957735A (en) * 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US6099842A (en) * 1990-12-03 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
DE69332485T2 (de) * 1992-08-11 2003-11-13 The President And Fellows Of Harvard College, Cambridge Immunmodulierende peptide
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
CA2245835A1 (en) * 1995-06-14 1997-01-03 The Regents Of The University Of California Novel high affinity human antibodies to tumor antigens
US6210707B1 (en) * 1996-11-12 2001-04-03 The Regents Of The University Of California Methods of forming protein-linked lipidic microparticles, and compositions thereof
JP2001510457A (ja) * 1996-11-12 2001-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア インビボ送達に有効な、脂質―核酸複合体の安定な製剤の調製
US6794128B2 (en) * 1998-04-24 2004-09-21 The Regents Of The University Of California Methods of selecting internalizing antibodies
US20030022854A1 (en) * 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US9034329B2 (en) * 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
ATE511543T1 (de) 1999-02-22 2011-06-15 Univ Georgetown Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
US20020103165A1 (en) * 2000-02-29 2002-08-01 Alliance Pharmaceutical Corp., Engineered spray-dried lipid-based microparticles for cellular targeting
PT1633327E (pt) 2003-06-04 2010-11-08 Univ Georgetown Método para melhoramento da estabilidade e duração de armazenamento de complexos lipossomais
AU2006304790B2 (en) * 2005-10-20 2013-06-27 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer

Similar Documents

Publication Publication Date Title
JP2010533178A5 (https=)
Aldosari et al. Lipid nanoparticles as delivery systems for RNA-based vaccines
US20240115691A1 (en) Coronavirus vaccine compositions and methods
Zhang et al. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
Yuan et al. mRNA nanodelivery systems: targeting strategies and administration routes
JP2011516586A5 (https=)
Tagami et al. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes
CN112867509A (zh) 包含聚肌氨酸的rna颗粒
WO2020069718A1 (en) Rna particles comprising polysarcosine
Zhang et al. Hybrids of nonviral vectors for gene delivery
EP4268808A1 (en) Lipid nanoparticles comprising mannose or uses thereof
CN107849567A (zh) 一种siRNA、含有该siRNA的药物组合物和缀合物及它们的应用
NZ588583A (en) Novel lipid formulations for nucleic acid delivery
CN101801344A (zh) 关于使用阳离子脂质体介导的核酸递送产生免疫应答的方法
EP4262761A4 (en) TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY 1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM PROPANE (DOTAP) LIPID DNANOPARTICLES
C Silva et al. Delivery systems for biopharmaceuticals. Part II: liposomes, micelles, microemulsions and dendrimers
TWI853485B (zh) 核酸-脂質奈米粒子及使用其之方法
Jallow et al. Versatility of LNPs across different administration routes for targeted RNA delivery
CN115087437A (zh) 脂质组合物及其用于将治疗活性剂递送至内皮的用途
CN119074950A (zh) 一种增强mRNA-LNP组织靶向递送的方法
TW202539711A (zh) 靶向抗原呈遞細胞的脂質組合物及其應用
KR20240083166A (ko) 폐를 표적장기로 하는 생분해성 지질나노입자 약물 전달 제형 및 이의 활용
WO2024094027A1 (zh) 用于增强核酸递送的组合物
EP4442256A1 (en) Lipid nanoparticle compositions
KR102921785B1 (ko) 핵산 전달용 사이클로알칸계 지질 화합물 및 이를 포함하는 지질 나노입자